Where is Ignyta headquartered?

Ignyta is located in San Diego, CA.

Who invested in Ignyta?

Ignyta has 13 investors including Geekdom Fund And Geekdom Fund.

When was the last funding round for Ignyta?

Ignyta closed its lastf unding roundon Jul 19, 2017 from a Convertible Note round.

Company Information
Company Timeline (Coming Soon)

ignyta.com

Ignyta

Ignyta develops and commercializes targeted molecule therapies for the treatment of cancer.

Business Model:

Revenue: $150k

Employees: 51-200

Ignyta was acquired by Roche.
The acquisition happend on 2017-12-22.
Details of the transaction were not public

Acquirer

Roche

General Information

Geographic Data

Address: 4545 Towne Centre Ct

City: San Diego

State: CA

Zip: 92121

Country: US

Financial Info

Stage:

post ipo equity

Raised Last:

$160M

Raised Total:

$347M

Social

Facebook

Twitter

Crunchbase

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

Ignyta develops and commercializes targeted molecule therapies for the treatment of cancer.

Contact Phone:
+18582555959

Contact Email:

IPO Details

Ignyta went public on 3/14/2014 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
3/14/2014

Ticker Symbol:
RXDX

IPO Price:
$17.5/share

Amount Raised:
$96M

Live

Opened: -/share

EBITDA	-
Total Cash	-
Total Debt	-
Total Revenue	-
Total Profit (Gross)	-
PE Ratio	-

Investments

Announced Date	Company	Transaction	Money Raised

Funding Rounds

Announced Date	Transaction	Number of Investors	Money Raised	Lead Investors
12/2012	Series B		$0	City Hill Ventures Colt Ventures Silicon Valley Bank City Hill Ventures Colt Ventures City Hill Ventures Colt Ventures Silicon Valley Bank City Hill Ventures Colt Ventures
12/2013	Venture Round	1	$54M	Casdin Capital Casdin Capital
9/2014	Debt		$31M	Silicon Valley Bank
3/2014	IPO		$48M
1/2014	Debt Financing	2	$10M	Silicon Valley Bank Frazier Healthcare Partners Silicon Valley Bank Frazier Healthcare Partners
10/2014	Post-IPO Debt	1	$31M	Silicon Valley Bank Silicon Valley Bank
3/2015	Post-IPO Equity		$0	Teva Pharmaceutical Industries Teva Pharmaceutical Industries
10/2017	Post-IPO Equity		$160M
11/2015	Post-IPO Equity		$30M
6/2016	Post-IPO Debt	2	$42M	Oxford Finance LLC Silicon Valley Bank Oxford Finance LLC Silicon Valley Bank
2/2013	Debt Financing		$1M
3/2015	Equity	1	$42M	Teva Pharmaceutical Industries Teva Pharmaceutical Industries
12/2012	Series B	3	$5.5M	City Hill Ventures Colt Ventures Silicon Valley Bank City Hill Ventures Colt Ventures City Hill Ventures Colt Ventures Silicon Valley Bank City Hill Ventures Colt Ventures

Acquisitions

Announced Date	Name	Price
5/2013	Actagene Oncology

Employee Demographics

Employee Departments

Employee States

Similar Companies

Uniview Singapore VEID	Revenue: 0 - 100000 Employees: Industry: Software	Details
Konkuk University Medical Center	Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education	Details
Daemon Technologies	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain	Details
Ace International Trade	Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial	Details
An Hòa Communications	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising	Details